Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 358

1.

Gold nanoparticles: emerging paradigm for targeted drug delivery system.

Kumar A, Zhang X, Liang XJ.

Biotechnol Adv. 2013 Sep-Oct;31(5):593-606. doi: 10.1016/j.biotechadv.2012.10.002. Review.

PMID:
23111203
2.

A mitochondria-targeting gold-peptide nanoassembly for enhanced cancer-cell killing.

Ma X, Wang X, Zhou M, Fei H.

Adv Healthc Mater. 2013 Dec;2(12):1638-43. doi: 10.1002/adhm.201300037.

PMID:
23657942
3.

Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent.

Patra CR, Bhattacharya R, Wang E, Katarya A, Lau JS, Dutta S, Muders M, Wang S, Buhrow SA, Safgren SL, Yaszemski MJ, Reid JM, Ames MM, Mukherjee P, Mukhopadhyay D.

Cancer Res. 2008 Mar 15;68(6):1970-8. doi: 10.1158/0008-5472.CAN-07-6102.

4.
5.

Multifunctional nanoparticles for drug delivery and molecular imaging.

Bao G, Mitragotri S, Tong S.

Annu Rev Biomed Eng. 2013;15:253-82. doi: 10.1146/annurev-bioeng-071812-152409. Review.

PMID:
23642243
6.

Gold nanoparticles in theranostic oncology: current state-of-the-art.

Akhter S, Ahmad MZ, Ahmad FJ, Storm G, Kok RJ.

Expert Opin Drug Deliv. 2012 Oct;9(10):1225-43. Review.

PMID:
22897613
7.

Targeting nanoparticles to cancer.

Wang M, Thanou M.

Pharmacol Res. 2010 Aug;62(2):90-9. doi: 10.1016/j.phrs.2010.03.005. Review.

PMID:
20380880
8.

The upcoming field of theranostic nanomedicine: an overview.

Prabhu P, Patravale V.

J Biomed Nanotechnol. 2012 Dec;8(6):859-82. Review.

PMID:
23029995
9.

Emerging advances in nanomedicine with engineered gold nanostructures.

Webb JA, Bardhan R.

Nanoscale. 2014 Mar 7;6(5):2502-30. doi: 10.1039/c3nr05112a. Review.

PMID:
24445488
10.

Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.

Bharali DJ, Mousa SA.

Pharmacol Ther. 2010 Nov;128(2):324-35. doi: 10.1016/j.pharmthera.2010.07.007. Review.

PMID:
20705093
11.

Gold nanoparticle-based drug delivery platform for antineoplastic chemotherapy.

Liang JJ, Zhou YY, Wu J, Ding Y.

Curr Drug Metab. 2014;15(6):620-31. Review.

PMID:
24909418
12.

Nanotechnology-based intelligent drug design for cancer metastasis treatment.

Gao Y, Xie J, Chen H, Gu S, Zhao R, Shao J, Jia L.

Biotechnol Adv. 2014 Jul-Aug;32(4):761-77. doi: 10.1016/j.biotechadv.2013.10.013. Review.

PMID:
24211475
13.

Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.

Pridgen EM, Langer R, Farokhzad OC.

Nanomedicine (Lond). 2007 Oct;2(5):669-80. Review.

PMID:
17976029
14.

Folate-conjugated gold nanoparticle as a new nanoplatform for targeted cancer therapy.

Samadian H, Hosseini-Nami S, Kamrava SK, Ghaznavi H, Shakeri-Zadeh A.

J Cancer Res Clin Oncol. 2016 Nov;142(11):2217-29. doi: 10.1007/s00432-016-2179-3. Review.

PMID:
27209529
15.

Inorganic nanoparticles in cancer therapy.

Bhattacharyya S, Kudgus RA, Bhattacharya R, Mukherjee P.

Pharm Res. 2011 Feb;28(2):237-59. doi: 10.1007/s11095-010-0318-0. Review.

16.

Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.

Fadeel B, Garcia-Bennett AE.

Adv Drug Deliv Rev. 2010 Mar 8;62(3):362-74. doi: 10.1016/j.addr.2009.11.008. Review.

PMID:
19900497
17.

Anticancer drug delivery with nanoparticles.

Conti M, Tazzari V, Baccini C, Pertici G, Serino LP, De Giorgi U.

In Vivo. 2006 Nov-Dec;20(6A):697-701. Review.

18.

Anti-cancer drug loaded iron-gold core-shell nanoparticles (Fe@Au) for magnetic drug targeting.

Kayal S, Ramanujan RV.

J Nanosci Nanotechnol. 2010 Sep;10(9):5527-39.

PMID:
21133071
19.
20.

Nanoparticles containing insoluble drug for cancer therapy.

Guo S, Huang L.

Biotechnol Adv. 2014 Jul-Aug;32(4):778-88. doi: 10.1016/j.biotechadv.2013.10.002. Review.

Supplemental Content

Support Center